0001493152-20-013071.txt : 20200710
0001493152-20-013071.hdr.sgml : 20200710
20200710125736
ACCESSION NUMBER: 0001493152-20-013071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200709
FILED AS OF DATE: 20200710
DATE AS OF CHANGE: 20200710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAMVAKAS ELIAS
CENTRAL INDEX KEY: 0001061865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51030
FILM NUMBER: 201022635
MAIL ADDRESS:
STREET 1: 5280 SOLAR DRIVE
STREET 2: SUITE 100
CITY: MISSISSAUGA
STATE: A6
ZIP: L4W 5M8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TearLab Corp
CENTRAL INDEX KEY: 0001299139
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 593434771
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9980 HUENNEKENS ST.
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-794-1400
MAIL ADDRESS:
STREET 1: 9980 HUENNEKENS ST.
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: OccuLogix, Inc.
DATE OF NAME CHANGE: 20040730
4
1
ownership.xml
X0306
4
2020-07-09
1
0001299139
TearLab Corp
TEAR
0001061865
VAMVAKAS ELIAS
150 LA TERRAZA BLVD., STE 101
ESCONDIDO
CA
92025
1
0
0
0
Common Stock
2020-07-09
4
U
0
20140
0.0586
D
0
D
Common Stock
2020-07-09
4
U
0
130813
0.0586
D
0
I
See footnote
Common Stock
2020-07-09
4
U
0
32000
0.0586
D
0
I
See footnote
Pursuant to the terms of the Agreement and Plan of Merger, dated May 11, 2020 (the "Merger Agreement"), among Accelmed Partners II LP, a Cayman Islands exempted limited partnership ("Buyer"), the Issuer and Accelmed Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Buyer, each issued and outstanding share of Issuer common stock and preferred stock (other than Cancelled Shares (as defined in the Merger Agreement)) was cancelled and automatically converted into the right to receive an amount equal to $0.0586 per share in cash, without interest and less any required withholding taxes, effective at the time of the Merger (as defined in the Merger Agreement).
Shares held by Greybrook Capital, Inc. The reporting person is an officer and a director of Greybrook Capital Inc. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Shares held by Greybrook Corporation. The reporting person is an officer and a director of Greybrook Corporation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ Elias Vamvakas
2020-07-09